Propofol containing sulfite-potential for injury.
Langevin
P B
PB
D017277:Drug Approval; D004342:Drug Hypersensitivity / Q000209:etiology*; D016568:Drugs, Generic / Q000009:adverse effects*; D006801:Humans; D010592:Pharmaceutic Aids / Q000009:adverse effects*; D015742:Propofol / Q000009:adverse effects*; D012307:Risk Factors; D013447:Sulfites / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D010592:Pharmaceutic Aids; D013447:Sulfites; C005200:sodium metabisulfite; D015742:Propofol